We should also mention that the patents that protect Keytruda and Optdivo can’t protect the owners from PD1 vax.
PD1 Vax is far cheaper to produce. And we are likely to see much less in the way of mast side effects.
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene Receives Third PD1-VAXX Ethics Trial Approval
IMU
imugene limited
Add to My Watchlist
3.57%
!
27.0¢

Ann: Imugene Receives Third PD1-VAXX Ethics Trial Approval, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $77.89M |
Open | High | Low | Value | Volume |
28.0¢ | 28.0¢ | 26.5¢ | $407.7K | 1.508M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 623451 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 66358 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 623451 | 0.265 |
32 | 264047 | 0.260 |
14 | 212547 | 0.255 |
29 | 171827 | 0.250 |
9 | 121914 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 66358 | 4 |
0.275 | 84237 | 4 |
0.280 | 182765 | 14 |
0.290 | 85790 | 5 |
0.295 | 103723 | 3 |
Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |